‘Striking’ Benefit of Intranasal Insulin in Slowing Dementia

Share this post

Extension trial showed striking results at 18 months in patients with mild cognitive impairment or dementia using a particular insulin delivery device.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply